The BFC 2018 Global Healthcare Business Development and Investment Conference in June will feature presentations from over 100 public & private healthcare companies across the biopharmaceuticals, IVD, medical device, and healthcare services sectors. This year’s flagship event invites key opinion leaders and industry experts from across the globe to explore opportunities and risks in the Hong Kong biotechnology capital market. Click here for more information.
The BFC 2018 Global Healthcare Business Development and Investment Conference will be held on June 13~15 at the Westin Bund Center Shanghai (http://www.westinshanghai.com/). The conference will feature presentations from over 100 public & private healthcare companies across the biopharmaceuticals, IVD, medical device, and healthcare services sectors. More than 200 strategic, PE and VC investors from over 150 firms also attended our conference last year.
This year’s flagship event invites key opinion leaders and industry experts from across the globe to explore opportunities and risks in the Hong Kong biotechnology capital market. The three-day conference will be comprised of company presentations, Q&A breakout sessions, panel discussions, and keynote presentations. Company management teams and investors can also participate in one-on-one meetings with others through conference online system.
This year’s flagship event invites key opinion leaders and industry experts from across the globe to explore opportunities and risks in the Hong Kong biotechnology capital market. The three-day conference will be comprised of company presentations, Q&A breakout sessions, panel discussions, and keynote presentations. Company management teams and investors can also participate in one-on-one meetings with others through conference online system.